
|Articles|September 1, 2002
Poll garners patient, prescriber opinions on AK treatments
New Orleans - Patients and physicians express various levels of satisfaction and dissatisfaction with the most common treatment modalities for actinic keratoses. Both groups have strong interest as well in newer therapies, according to the results of a survey presented by James Q. Del Rosso, D.O., at the annual meeting of the American Academy of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
3
Dermatology Conferences and Meetings Calendar: December 2025
4
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
5


















